ABOUT
SCIENCE
PIPELINE
AR-001
NEWS & PUBLICATIONS
CONTACT US
Contact
Breathing Should Be Easy
We're developing a novel inhaled therapy to treat respiratory disease
1 in 10 people have asthma costing $90 billion annually in the US
33 million worldwide suffer from inadequately controlled asthma
1,2
COPD recognized by WHO as third leading cause of death worldwide
In asthma and COPD, smooth muscle tightening, excess mucus production, inflammation and infections all contribute to airway narrowing
Normal Airways are unobstructed and support easy breathing
How We are Simplifying Respiratory Health
By focusing on the ROOT CAUSES OF DISEASE - knowing how to SHUT IT DOWN - and empowering patients to TAKE CONTROL
Learn More